Furthermore, limited insights into the spatial and temporal regulation of FGFR2 activation in iCCA continue to hinder mechanistic understanding and the development of next-generation FGFR2-targeted therapies. Here, FGFR2 is linked to infantile convulsions and choreoathetosis.